TSG Advice Partners LLC Buys New Holdings in Cardinal Health, Inc. $CAH

TSG Advice Partners LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 13,804 shares of the company’s stock, valued at approximately $3,279,000.

A number of other institutional investors have also made changes to their positions in CAH. Downshift Financial LLC raised its stake in Cardinal Health by 3,666.7% in the 3rd quarter. Downshift Financial LLC now owns 113 shares of the company’s stock valued at $25,000 after acquiring an additional 110 shares during the period. Investors Research Corp bought a new position in Cardinal Health during the second quarter worth $29,000. Maryland Capital Advisors Inc. boosted its position in Cardinal Health by 12,600.0% during the third quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock worth $28,000 after purchasing an additional 126 shares during the period. Allied Private Wealth LLC acquired a new position in shares of Cardinal Health in the second quarter valued at $30,000. Finally, NBH Bank acquired a new position in shares of Cardinal Health in the second quarter valued at $31,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CAH shares. Wells Fargo & Company increased their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Robert W. Baird upped their price target on shares of Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a research note on Wednesday, August 12th. Evercore reissued an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. TD Cowen raised their price objective on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Finally, Barclays lifted their target price on Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, August 13th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $270.69.

Cardinal Health Trading Up 1.7%

Shares of Cardinal Health stock opened at $254.69 on Tuesday. The firm’s 50 day moving average is $238.24 and its 200 day moving average is $222.52. The firm has a market capitalization of $58.98 billion, a PE ratio of 35.23, a price-to-earnings-growth ratio of 1.47 and a beta of 0.50. Cardinal Health, Inc. has a 1 year low of $180.45 and a 1 year high of $259.84.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter in the prior year, the firm earned $2.08 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were issued a dividend of $0.5158 per share. The ex-dividend date was Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. Cardinal Health’s dividend payout ratio is 28.49%.

Insider Buying and Selling

In related news, CEO Stephen M. Mason sold 35,000 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the sale, the chief executive officer owned 18,061 shares in the company, valued at $4,269,620.40. The trade was a 65.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jason M. Hollar sold 80,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.74, for a total value of $18,859,200.00. Following the completion of the transaction, the chief executive officer directly owned 235,132 shares of the company’s stock, valued at approximately $55,430,017.68. The trade was a 25.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 210,271 shares of company stock worth $49,626,657 in the last ninety days. Insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.